Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Departments of Labor, the Treasury, and Health and Human Services relating to "Short-Term, Limited-Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage".
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™House Joint Resolution 129 (HJRES 129) from the 118th Congress is a legislative measure aimed at disapproving a rule jointly submitted by the Departments of Labor, the Treasury, and Health and Human Services. The rule in question relates to regulations governing Short-Term, Limited-Duration Insurance (STLDI) and Independent, Noncoordinated Excepted Benefits Coverage. The resolution seeks to nullify this rule under the Congressional Review Act, which allows Congress to overturn federal regulations. The bill was referred to the Subcommittee on Health but ultimately failed or expired without becoming law. No full bill text or official summary is available, limiting detailed analysis of specific provisions.
HJRES 129 attempted to disapprove a federal rule on short-term health insurance and excepted benefits but did not advance beyond subcommittee referral and expired without enactment.
- The resolution targets a rule jointly issued by the Departments of Labor, Treasury, and Health and Human Services concerning short-term, limited-duration insurance and excepted benefits.
- It was introduced in the House and referred to the Subcommittee on Health but did not progress further.
- The bill is categorized under the health policy area and uses the Congressional Review Act process to attempt disapproval of the rule.
["Federal agencies involved in health insurance regulation (Departments of Labor, Treasury, Health and Human Services) may see clarified regulatory authority depending on the rule's status.", "Stakeholders in the short-term health insurance market, including insurers and consumers, could be affected by the rule's approval or disapproval.", 'Congressional committees overseeing health policy have a role in reviewing such regulatory actions.']
["Lack of available full bill text and official summary limits transparency and detailed understanding of the resolution's specific provisions.", 'The use of the Congressional Review Act to disapprove rules can raise questions about the balance of regulatory authority between the executive branch and Congress.', 'Potential implementation challenges could arise if the rule were disapproved, affecting existing insurance products and market stability.']
HJRES 129 was introduced during the 118th Congress as part of a legislative effort to challenge a federal rule on short-term health insurance products. The Congressional Review Act provides a mechanism for Congress to overturn recently issued federal regulations, reflecting ongoing debates about the scope and oversight of health insurance regulations. The bill’s referral to the Subcommittee on Health indicates its placement within the health policy legislative framework. The resolution ultimately failed or expired, indicating it did not secure sufficient legislative support or priority.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If the rule had been disapproved, it could have led to regulatory uncertainty for short-term health insurance markets, potentially affecting consumer access and insurer offerings.', 'Disapproval might have influenced future regulatory approaches by the involved federal departments, possibly affecting the pace and scope of health insurance rulemaking.', 'Legislative use of the Congressional Review Act in this context may impact executive agencies’ willingness to issue similar rules.']
The absence of a full bill text and official summary restricts comprehensive oversight and public understanding of the resolution’s specific content and implications. Monitoring the use of the Congressional Review Act in health policy contexts is important for transparency regarding shifts in regulatory authority. The bill’s failure to advance beyond subcommittee referral suggests limited legislative momentum, but the procedural attempt to disapprove a multi-agency rule highlights ongoing tensions in health insurance regulation oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.